A New Era of Technological Transformation in GM PHARMA’s Manufacturing!
The international, multinational pharmaceutical company GM PHARMA has once again reaffirmed its leadership in technological innovation. The company is integrating two next-generation, high-technology machines developed by the Italian IMA Group into its production line: the ADAPTA 100 high-precision capsule filling machine and the HERMETICA 100 capsule sealing system. It is noteworthy that globally, only 4 to 5 leading pharmaceutical companies operate with this level of advanced technology, while in the South Caucasus, GM PHARMA is the only company equipped with such advanced capabilities.
This investment is part of GM PHARMA's long-term development strategy. It serves the company's strategic goals: the technological modernization of production, the automation of quality control and the integration of innovative technologies. With this step, GM PHARMA strengthens its position as the most technologically advanced pharmaceutical manufacturer in the region.
ADAPTA 100 is a high-tech machine that ensures maximum precision, flexibility and quality control during the capsule-filling process. The machine can fill capsules with various types of materials: powder, granules (pellets), micro-tablets and liquid, as well as combinations of these. Meanwhile, HERMETICA 100 performs the hermetic sealing of capsules - the machine applies a gelatin ring to the outer surface of each capsule, ensuring a 100% hermetic seal. The machine's ergonomic design provides maximum visibility and optimal access to every stage of the technological process. The operating speed of the HERMETICA 100 (100,000 caps/hour) and its other parameters are fully aligned with those of the ADAPTA 100, enabling full process synergy between the two machines.
The technological advantages and functional capabilities of these machines significantly enhance production efficiency. In particular, the ADAPTA 100 is capable of producing up to 100,000 capsules per hour. This capacity substantially increases manufacturing productivity and ensures maximum optimization of the production process.
Integrated into the system is 100% weight control, each capsule is checked in real-time, which eliminates potential dosing deviations, reduces the amount of waste and ensures constant quality stability.
This technological upgrade is a significant step forward for GM PHARMA. In the near future, this innovation will substantially strengthen the company's Research and Development (R&D) processes for new pharmaceuticals. This means that new preparations will soon appear in Georgia and all countries where GM PHARMA operates. These innovations will offer healthcare professionals and patients more effective options for managing health conditions.
Most importantly, both IMA machines fully comply with the requirements of global and EU GMP (Good Manufacturing Practice) standards, creating a strong foundation for GM PHARMA to enhance its position in the European Union market.
The Italian company IMA, founded in 1961, is a global leader in the design and production of automatic machinery for processing and packaging of pharmaceutical, cosmetic, tea, coffee and food products. The company currently operates 54 production facilities across Italy, Germany, France, Switzerland, Spain, the United Kingdom, the United States, India, Malaysia, China and Argentina. IMA’s products are represented in more than 80 countries worldwide.
The implementation of ADAPTA 100 and HERMETICA 100 represents not only another stage of technological development and compliance with modern production standards for GM PHARMA, but also the logical continuation of the company's 25 years of progress. Throughout its quarter-century history, GM PHARMA's strategy has always been based on continuous renewal, quality, innovation and compliance with international order. It is precisely this vision that has ensured the company's establishment as the region's leader, creating its success story through a commitment to high-quality standards.
Let us remind you that the international pharmaceutical company GM PHARMA's plant in Tbilisi is a leading pharmaceutical production facility in the Caucasus region, which possesses a complete technological cycle for the production of solid dosage forms of medicines. The complete technological cycle includes the process from sourcing raw materials to the release of the final product: dispensing, blending, granulation, tableting, tablet coating, capsule filling, bottle filling, sachet filling and blister and bottle packaging, quality control.
Since its founding, the company's mission and values have remained unchanged – based on scientific approaches and industry best practices, continuous improvement of quality and products, the production and supply medicines that improve and prolong patients’ lives.
GM PHARMA – serving those who need it most!